Aron Marquitz
About Aron Marquitz
Aron Marquitz is a Health Specialist currently employed at the National Institutes of Health, where he has worked since 2015. He has held various positions in research and program management, including roles at the University of North Carolina and the National Institute of Arthritis and Musculoskeletal and Skin Disease.
Work at National Institutes of Health
Aron Marquitz has been employed at the National Institutes of Health (NIH) since 2015. He currently holds the position of Health Specialist. In this role, he contributes to various health-related initiatives and programs. Prior to his current position, he served as a Scientific Program Analyst at the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) from 2019 to 2020. His experience at NIH spans several years, allowing him to engage in significant health research and program development.
Education and Expertise
Aron Marquitz earned his Bachelor’s Degree in Molecular Biology from the University of Pittsburgh, where he studied from 1995 to 1999. He furthered his education at Duke University, obtaining a Ph.D. in Molecular Cancer Biology from 1999 to 2005. His academic background provides a strong foundation for his work in health research and program management, particularly in the fields of arthritis, musculoskeletal disorders, and skin diseases.
Background
Before joining the NIH, Aron Marquitz worked at the University of North Carolina as a Research Associate from 2006 to 2015. During this nine-year tenure, he was involved in various research projects that contributed to the understanding of health issues. His transition to NIAMS allowed him to apply his research experience in a more focused capacity, first as a Scientific Program Analyst and later as a Program Director.
Current Role as Program Director
Since 2020, Aron Marquitz has served as Program Director at the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS). In this role, he oversees programs related to arthritis, musculoskeletal, and skin diseases. His leadership is essential in guiding research initiatives and ensuring alignment with the institute's mission to improve health outcomes in these areas.